Menu Close

Forum

Notifications
Clear all

Tianeptine is controlled or not ?  

  RSS
Pain Relief
(@dealpain)
Member Admin

In the U.S., tianeptine is not a controlled substance under the Controlled Substances Act, except in Michigan. It is, however, not approved by the FDA for medical use within the U.S. The treatment approach for tianeptine abuse is similar to that for opioid addiction.

Tianeptine, sold under the brand names Stablon and Coaxil among others, is an atypical antidepressant which is used mainly in the treatment of major depressive disorder, although it may also be used to treat anxiety, asthma, and irritable bowel syndrome.

Tianeptine has antidepressant and anxiolytic effects with a relative lack of sedative, anticholinergic, and cardiovascular side effects. It has been found to act as an atypical agonist of the μ-opioid receptor with clinically negligible effects on the δ- and κ-opioid receptors as do most tricyclic antidepressants (TCA).

Tianeptine was discovered and patented by the French Society of Medical Research in the 1960s. Currently, tianeptine is approved in France and manufactured and marketed by Laboratories Servier SA; it is also marketed in a number of other European countries under the trade name Coaxil as well as in Asia (including Singapore) and Latin America as Stablon and Tatinol but it is not available in Australia, Canada, New Zealand, the United Kingdom, or the United States.

Quote
Posted : 05/05/2020 1:28 pm
Share: